Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 11844

Finally; it’s a start at least.

This week, the Federal government took the first steps toward implementation of the The Cybersecurity Information Sharing Act (CISA), enacted into law last December. CISA aims to encourage sharing of cyber threat indicators and defensive measures among private companies and between the private sector and the Federal government by providing liability protection for sharing such information in accordance with the Act. The DHS Federal Register notice was published this morning here.

As required by the Act, the government has released four pieces of guidance designed to assist companies and Federal agencies with respect to sharing, receiving and handling cyber threat information.

Read more

A complete cognitive architecture to implement systems that are self-aware and capable of intentional mutations. Now available at mecasapiens.com.

HALIFAX, CANADA, February 16, 2016 (Newswire.com) — Monterège Design Inc. is pleased to announce the publication of a cognitive architecture to implement synthetic consciousness. The systems based on this architecture will be fully autonomous, self-aware and capable of intentional mutations. The architecture, published under the title The Meca Sapiens Blueprint, is complete and ready for design and implementation. It can be purchased on line at mecasapiens.com.

Read more

Researchers have developed a functioning miniature replica of the human brain, composed of neurons and glial cells, to help study and better understand neurological diseases.

A tiny ball of brain cells may help researchers alleviate or treat neurological diseases.

These small cellular balls act like miniature versions of the human brain, mimicking various aspects of the actual brain that include sending pulses of electric signals akin to what happens in a thinking mind. This research was reported at the annual meeting of the American Association for the Advancement of Science in Washington.

Read more

What would it mean if you lost all of your personal documents, such as your family photos, research or business records? How much would you pay to get them back? There’s a burgeoning form of cybercrime that hinges on the answers to these questions.

You have probably heard of viruses and malware. These dangerous pieces of software can make their way into your computer and wreak havoc. Malware authors are intent on stealing your data and disrupting the proper functioning of your digital devices.

Then there is ransomware. This is crafted by cyber-criminals for extorting data from innocent users, and is rapidly becoming a threat to individuals, small business and corporate users alike.

Read more

How robotics is making live music a more enriching experience.

Scientists have developed a ‘smart’ wearable robotic limb that responds to human gestures and the music it hears, allowing drummers to play with three arms.

The two-foot long robotic arm can be attached to a musician’s shoulder, and knows what to play by listening to the music in the room. It improvises based on the beat and rhythm. For instance, if the musician plays slowly, the arm slows the tempo. If the drummer speeds up, it plays faster.

Another aspect of its intelligence is knowing where it is located at all times, where the drums are, and the direction and proximity of the human arms.

Continue reading “Robot limb lets drummers play with three arms” | >

The facts about the CRISPR Patent.

Xconomy San Francisco —

If you ask people who don’t follow biotech too closely what they know about CRISPR, you might get two answers: genetic editing and a big patent fight.

But a new CRISPR patent highlights a lower-profile potential use for the biotechnology: genetic detection and analysis.

Continue reading “Caribou Bio’s New CRISPR Patent Isn’t About Gene Editing” | >

New insights on GBM resistance markers.

A research team, with the participation of the University of Granada (UGR), has made some progress in determining the causes for glioblastoma multiforme (GBM), one of the most aggressive brain tumors known, to be resistant to the drugs currently used, which is one of the main limitations of its treatment. The results have been recently published in two articles in PlosOne magazine.

The researchers have proven that proteoglycans (the cells’ structural elements), called decorin (DCN) and lumican (LUM), could be decisive in the behavior and development of a resistance to the drugs used for treating glioblastoma multiforme, such as temozolamide (TMZ). In the other hand, they have laid bare that the inhibition of the transcription of some of the sub-units belonging to the mismatch-repair (MMR) complex, a system that analyzes and repairs DNA, could be responsible of the failure of current therapies against this kind of tumor.

This is a scientific breakthrough that could be useful for the search of new resistance markers in GBM as well as for the development of new therapeutic strategies which avoid the resistance to drugs that these tumors possess.

Continue reading “GBM Treatment Discoveries: Why Select Drugs Might not Work” | >